Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study

Xinyi Hong,1,* Shanhu Qiu,2,* Xia Wu,3 Sizhen Chen,4 Xiaoxiang Chen,5 Bei Zhang,6 Aiqin He,3 Yun Xu,7 Jianqing Wang,8 Yingchun Gao,9 Xizhong Xu,10 Li Sun,11 Yang Zhang,12 Libing Xiang,13 Jundong Zhou,14 Qun Guan,15 Yanling Zhu,16 Haiyan Liu,17 Hao Xu,18 Ying Zhou,19 Bingwei Chen,4 Ya...

Full description

Bibliographic Details
Main Authors: Hong X, Qiu S, Wu X, Chen S, Chen X, Zhang B, He A, Xu Y, Wang J, Gao Y, Xu X, Sun L, Zhang Y, Xiang L, Zhou J, Guan Q, Zhu Y, Liu H, Xu H, Zhou Y, Chen B, Shen Y
Format: Article
Language:English
Published: Dove Medical Press 2023-07-01
Series:Drug Design, Development and Therapy
Subjects:
molecular-targeting therapy
angiogenesis inhibitors
real-world study
Online Access:https://www.dovepress.com/efficacy-and-safety-of-anlotinib-in-overall-and-disease-specific-advan-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-anlotinib-in-overall-and-disease-specific-advan-peer-reviewed-fulltext-article-DDDT

Similar Items